These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2874448)
1. Acid-base effects of "non-systemic" antacids. Wrong O Lancet; 1986 Aug; 2(8504):462-3. PubMed ID: 2874448 [No Abstract] [Full Text] [Related]
2. [Do antacids with high acid-binding capacity modify mineral metabolism?]. Dollinger HC; Holzberg E Fortschr Med Suppl; 1987; 19():10-4. PubMed ID: 2883095 [No Abstract] [Full Text] [Related]
3. Magaldrate and almasilate--complex buffering antacids. Drug Ther Bull; 1985 May; 23(10):39-40. PubMed ID: 3888581 [No Abstract] [Full Text] [Related]
4. [Effect of antacids on mineral metabolism in persons with healthy kidneys. Double-blind study using an antacid containing magnesium aluminum silicate hydrate]. Herzog P; Holtermüller KH MMW Munch Med Wochenschr; 1982 Oct; 124(42):921-3. PubMed ID: 6298611 [No Abstract] [Full Text] [Related]
5. [The choice of an antacid in therapy: use of in vivo methods]. Caulin C; Isal JP Gastroenterol Clin Biol; 1983 Nov; 7(11):931. PubMed ID: 6653980 [No Abstract] [Full Text] [Related]
6. The bio-availability of beta-acetyldigoxine alone and combined with aluminum hydroxide and magnesium hydroxide (Alucol). Bonelli J; Hruby K; Magometschnigg D; Hitzenberger G; Kaik G Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):337-9. PubMed ID: 892951 [TBL] [Abstract][Full Text] [Related]
7. Diminished absorption of cimetidine caused by antacids. Bodemar G; Norlander B; Walan A Lancet; 1979 Feb; 1(8113):444-5. PubMed ID: 84296 [No Abstract] [Full Text] [Related]
8. Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux. Sutphen JL; Dillard VL; Pipan ME Pediatrics; 1986 Jul; 78(1):55-7. PubMed ID: 3725503 [TBL] [Abstract][Full Text] [Related]
9. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids. Beneyto JE; Fábregas JL Arzneimittelforschung; 1984; 34(10A):1357-60. PubMed ID: 6391496 [TBL] [Abstract][Full Text] [Related]
10. [Serum and urine electrolyte behavior under therapeutic dosage of a potent magnesium and aluminum hydroxide containing antacid]. Grünzig G; Lücker PW; Schnitker J Arzneimittelforschung; 1983; 33(2):258-62. PubMed ID: 6682667 [TBL] [Abstract][Full Text] [Related]
11. [Mineral metabolism and aluminum burden with hydrotalcit. A placebo-controlled randomized double-blind study]. Dollinger HC Fortschr Med; 1991 Jun; 109(18):385-8. PubMed ID: 1916557 [TBL] [Abstract][Full Text] [Related]
12. The treatment of malabsorption in cystic fibrosis with pancreatic extracts and inhibition of gastric acidity by antacids and cimetidine. Mitchell EA; Wesley AW; Elliott RB Aust Paediatr J; 1981 Jun; 17(2):89-92. PubMed ID: 7305775 [No Abstract] [Full Text] [Related]
13. Effect of antacids on the plasma concentration of phenoperidine. Calvey TN; Milne LA; Williams NE; Chan K; Murray GR Br J Anaesth; 1983 Jun; 55(6):535-9. PubMed ID: 6860522 [TBL] [Abstract][Full Text] [Related]
14. Activated aluminum complex derived from solubilized antacids exhibits enhanced cytoprotective activity in the rat. DiJoseph JF; Borella LE; Mir GN Gastroenterology; 1989 Mar; 96(3):730-5. PubMed ID: 2914636 [TBL] [Abstract][Full Text] [Related]
15. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)]. Baur C; Becker A; Linder R; Schwan T Arzneimittelforschung; 1981; 31(3):504-7. PubMed ID: 6784737 [TBL] [Abstract][Full Text] [Related]
16. [Effects of magaldrate on circadian profile of gastric juice pH in medical intensive care patients (author's transl)]. Dammann HG; Flashoff D; Müller P; Kather H; Simon B Dtsch Med Wochenschr; 1981 Oct; 106(44):1457-8. PubMed ID: 7297433 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the antacid properties of almagate and aluminium hydroxide against pentagastrin-induced gastric secretion in healthy volunteers. Balanzó J; Guarner C; Vilardell F Arzneimittelforschung; 1984; 34(10A):1375-7. PubMed ID: 6439225 [TBL] [Abstract][Full Text] [Related]
18. Long-term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis. Oe PL; Lips P; van der Meulen J; de Vries PM; van Bronswijk H; Donker AJ Clin Nephrol; 1987 Oct; 28(4):180-5. PubMed ID: 3690899 [TBL] [Abstract][Full Text] [Related]